SOURCE: Alpharma Inc.

April 25, 2008 15:08 ET

Alpharma to Present at Morgan Stanley Global Healthcare Unplugged Conference

BRIDGEWATER, NJ--(Marketwire - April 25, 2008) - Alpharma Inc. (NYSE: ALO), a leading global specialty pharmaceutical company, announced today that senior management will provide an overview of the company's business at the Morgan Stanley Global Healthcare Unplugged Conference on Friday, May 2, 2008 at 10:30AM Eastern Daylight Time. The conference will be held at The Ritz Carlton in Key Biscayne, Florida.

This presentation will be webcast live and can be accessed through Alpharma's website, www.alpharma.com, through its Investor Support and Company Calendar tabs.

An archived version will be available one hour after the live presentation and for one year through May 2, 2009 and can be accessed at the same location.

Alpharma press releases are also available at our website. www.alpharma.com

About Alpharma

Alpharma Inc. (NYSE: ALO) is a global specialty pharmaceutical company with leadership positions in products for humans and animals. Alpharma is presently active in more than 80 countries. Alpharma has a growing branded pharmaceutical franchise in the U.S. pain market with its KADIAN® (morphine sulfate extended-release) Capsules, and the FLECTOR® Patch (diclofenac epolamine topical patch). Alpharma is also internationally recognized as a leading provider of pharmaceutical products for poultry and livestock.

Contact Information

  • Contact:
    Jack Howarth
    Vice President, Investor Relations
    908-566-4153
    Email Contact